idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosupressandid - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
vitaprost süstelahuse pulber
biopharma llc - prostata ekstrakt - süstelahuse pulber - 10mg 10tk
crisantaspase porton biopharma süste-/infusioonilahuse pulber
almac pharma services limited - asparaginaas - süste-/infusioonilahuse pulber - 10000tÜ 5tk
amoxicillina sodica 1g süste-/infusioonilahuse pulber
biopharma s.r.l. - amoksitsilliin - süste-/infusioonilahuse pulber - 1g 50tk
jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artriit, reumatoidartriit - immunosupressandid - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.
euphyllin süstelahus
ao biopharm - aminofülliin - süstelahus - 24mg 1ml 10ml 10tk
amos zwarte zalf salv
kommer biopharm bv - ihtammool+kamper - salv - 150mg+100mg 800g 1tk
analgin süstelahus
ao biopharm - naatriummetamisool - süstelahus - 500mg 1ml 2ml 10tk
thiamin hcl süstelahus
ao biopharm - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
dimedrol süstelahus
ao biopharm - difenhüdramiin - süstelahus - 10mg 1ml 1ml 10tk